Sun Pharma recalls select eye drops in India after contamination concern
Sun Pharma has halted billing and distribution of specified eye-drop products, asking Indian distributors to report inventory and return all stocks as a precaution following a contamination scare.
Sun Pharma has halted distribution and recalled specified eye-drop products from Indian channels as a precaution following a contamination scare, asking distributors to stop billing, report inventory and return all stocks.
Why this matters
The recall extends Sun Pharma’s recent precautionary halt and recall of multiple eye drops, while contrasting with its Q1FY27 results, when profit rose 27% and India formulations grew 16%.
Retail-company signals are accelerating, up +220867% QoQ.